Tradestie Institutional Equity Comparison Engine

MCHPP vs NOVTU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MCHPP Overall Edge

MCHPP Captures Institutional Edge (2โ€“0 Pillars ยท 6โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, MCHPP trades at N/M Forward P/E with 21.6% operating margin (+42.2% YoY revenue) versus NOVTU at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MCHPP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NOVTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MCHPP N/M vs NOVTU N/M Fwd P/E
Growth & Margin Winner MCHPP
Op Margin 21.6% vs N/A ยท YoY +42.2% vs N/A
Momentum & Technical Winner MCHPP
1Y +0.8% vs -2.4% ยท 52W Pos 14% vs 11%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MCHPP NASDAQ
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Semiconductors & Related Devices
$52.64
-3.18% 1D
Market Cap N/A
1M Return -17.41%
1Y Return +0.8%
Forward P/E N/M
Unified AI Score
57.1 / 100 HOLD
Tech 74.0 Fund 61.0 Flow 50.0 Mom 60.0
NOVTU US Equity
NOVTU
Institutional Equity
$50.76
-1.05% 1D
Market Cap N/A
1M Return -9.21%
1Y Return -2.38%
Forward P/E N/M
Unified AI Score
42.5 / 100 HOLD
Tech 30.0 Fund 45.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MCHPP +0.8% NOVTU -2.38% Spread: +1.29 pp (MCHPP Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MCHPP TTM Op. Margin: 21.6% NOVTU TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MCHPP vs NOVTU. Trailing 12-month operating profitability (MCHPP 21.6% vs NOVTU N/A) and valuation multiples (MCHPP N/M vs NOVTU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MCHPP (6) vs NOVTU (0)
Institutional Metric MCHPP NOVTU Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +42.2% N/A Higher Growth MCHPP
Operating Margin (TTM) Profitability 21.6% N/A Higher Margin MCHPP
Net Profit Margin Profitability 15.0% N/A Higher Margin MCHPP
Return on Equity (ROE) Capital Efficiency 12.6% N/A Higher ROE MCHPP
52-Week Range Position Momentum 14% ($47โ€“$88) 11% ($48โ€“$77) Stronger Trend MCHPP
Beta / 30D Volatility Risk Regime 2.16ฮฒ ยท 65% Vol 1.70ฮฒ ยท 65% Vol Lower Realized Risk Tie
Unified Institutional Score Composite Signal 57.1 / 100 (HOLD) 42.5 / 100 (HOLD) Higher Composite MCHPP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MCHPP vs NOVTU Buy Guide
MCHPP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MCHPP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NOVTU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NOVTU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MCHPP nor NOVTU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.